Department of Psychology, Institute for Mental Health and Behavioral Medicine, HMU Health and Medical University, Potsdam, Germany.
Faculty of Psychology, Institute of Clinical Psychology and Psychotherapy, Behavioral Epidemiology, Technische Universität Dresden, Dresden, Germany.
PLoS One. 2023 Jun 8;18(6):e0286750. doi: 10.1371/journal.pone.0286750. eCollection 2023.
Applied Relaxation (AR) is an established behavioral mental health intervention, but its efficacy in real life contexts remains unclear. Using randomized controlled trial data, we examined whether AR can effectively reduce mental health problems in daily life. A sample of 277 adults with increased psychopathological symptoms but without 12-month DSM-5 mental disorders at study entry was randomly assigned to an intervention group receiving AR training (n = 139) and an assessment-only control group (n = 138). Ecological momentary assessments were used to assess psychological outcomes in daily life over a period of seven days at baseline, post, and 12-month follow-up, respectively. Multilevel analyses indicated that all psychopathological symptoms decreased more in the intervention group than in the control group from baseline to post (range β = -0.31 for DASS-depression to β = -0.06 for PROMIS-anger). However, from post to follow-up, psychopathological symptoms decreased more in the control group than in the intervention group, so that only the intervention effects for PROMIS-depression (β = -0.10) and PROMIS-anger (β = -0.09) remained until follow-up. Moreover, positive affect (β = 0.19), internal control beliefs (β = 0.15), favorable coping (β = 0.60), and unfavorable coping (β = -0.41) improved more in the intervention group than in the control group, and these effects were mostly maintained in the long term. Some effects were stronger among women, older individuals, and individuals with higher initial symptoms. These findings suggest that AR can effectively reduce mental health problems in daily life. Trial registration. The trial has been registered at ClinicalTrials.gov (NCT03311529).
应用放松(AR)是一种已确立的行为心理健康干预方法,但它在现实生活环境中的疗效仍不清楚。使用随机对照试验数据,我们研究了 AR 是否可以有效地减轻日常生活中的心理健康问题。研究开始时,一组 277 名患有增加的精神病理学症状但无 12 个月 DSM-5 精神障碍的成年人被随机分配到干预组(接受 AR 训练,n = 139)和仅评估对照组(n = 138)。分别在基线、后测和 12 个月随访时使用生态瞬时评估来评估日常生活中的心理结果。多层次分析表明,与对照组相比,干预组从基线到后测时所有精神病理学症状均有更大程度的下降(DASS-抑郁范围β=-0.31,PROMIS-愤怒β=-0.06)。然而,从后测到随访时,对照组的精神病理学症状下降幅度大于干预组,因此,只有干预对 PROMIS-抑郁(β=-0.10)和 PROMIS-愤怒(β=-0.09)的影响持续到随访。此外,干预组的积极情绪(β=0.19)、内部控制信念(β=0.15)、有利应对(β=0.60)和不利应对(β=-0.41)改善幅度大于对照组,并且这些影响在长期内大多得到维持。一些影响在女性、年龄较大的个体和初始症状较高的个体中更强。这些发现表明 AR 可以有效地减轻日常生活中的心理健康问题。试验注册。该试验已在 ClinicalTrials.gov(NCT03311529)注册。